z-logo
Premium
Hypolipidemic Activity of New Phenoxyacetic Derivatives Related to α‐Asarone with Minimal Pharmacophore Features
Author(s) -
Cruz María del Carmen,
Salazar María,
Garciafigueroa Yésica,
Hernández Dolores,
Díaz Francisco,
Chamorro Germán,
Tamariz Joaquín
Publication year - 2003
Publication title -
drug development research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.582
H-Index - 60
eISSN - 1098-2299
pISSN - 0272-4391
DOI - 10.1002/ddr.10281
Subject(s) - pharmacophore , chemistry , clofibrate , pharmacology , stereochemistry , drug , biological activity , chemical synthesis , structure–activity relationship , biochemistry , in vitro , biology
Five new series of potential hypolipidemic agents 3–7 were synthesized, in order to establish the minimal pharmacophore features associated to the potent hypocholesterolemic activity of natural α‐asarone ( 1 ) and synthetic clofibrate mimetic derivatives 2 . The compounds were examined in hyperlipidemic male mice after oral administration of 25, 50, and 100 mg/Kg for 6 days. The isomeric series of acids and esters 3a–3c and 4a–4c were unexpectedly less active than the most simple structural isomeric compounds 5–7 . This reveals that the phenoxyacetic acid scaffold carrying a hydrocarbon side chain, also found in derivatives 2 , seems to be the most favorable lead for further development of potent hypolipidemic drugs. Drug Dev. Res. 60:186–195, 2003. © 2003 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom